Type 1 diabetes trials in Poland

In Poland 17 Also abroad 539

17 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults
Where
Warsaw
Age
1 year to 35 years
People
150 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07222137 · EU 2025-521797-34-00
Phase 3Taking people
A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
Where
Gdansk, Lodz, Warsaw, Wroclaw
Age
1 year to 35 years
People
300 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07222332 · EU 2025-522170-36-00
Phase 3Taking people
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Where
Bialystok, Cracow, Elblag, Gdynia, Katowice, Legnica, Lodz, Poznan, Radzionkow, Warsaw, Wroclaw
Age
18 years and over
People
2,500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07784725 · EU 2025-523379-41-00
No phaseTaking people
Clinical Study to Evaluate the Impact of the Accu-Chek SmartGuide CGM Solution on the Mean Change in Time in Range Compared With Self-Monitoring of Blood Glucose in Participants With Type 1 and Type 2 Diabetes Mellitus
Where
Gdansk, Krakow, Kraśnik, Lublin, Nadarzyn, Warsaw
Age
18 years and over
People
270 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT06704672
Phase 4Taking people
Anti-viral action against Type 1 diabetes autoimmunity GPPAD-05-AVAnT1A
Where
Lodz, Warsaw
Age
Up to 17 years
People
2,365 worldwide
Run by
Klinikum rechts der Isar der TU Muenchen AöR
See details and how to join2023-507348-35-00 · EU 2023-507348-35-00
Phase 3Taking people
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
Where
Bialystok, Lodz, Lublin, Warsaw
Age
1 year to 25 years
People
723 worldwide
Run by
Sanofi
See details and how to joinNCT07088068
Phase 2Taking people
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
Where
Opole, Poznan, Warsaw
Age
5 years to 40 years
People
159 worldwide
Run by
SAb Biotherapeutics, Inc.
See details and how to joinNCT07187531 · EU 2025-521560-36-00
Phase 3Taking people
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
Where
Bialystok, Białystok, Bydgoszcz, Cracow, Debica, Katowice, Poznan, Rzeszow, Warsaw, Wroclaw
Age
18 years and over
People
2,500 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07564414 · EU 2025-522488-14-00
Phase 3Taking people
A trial to learn how safe elecoglipron is and how well it works in adults living with obesity or excess body weight with or without type 2 diabetes
Where
Bialystok, Bydgoszcz, Cracow, Kielce, Lodz, Lublin, Poznan, Radom, Warsaw, Warszawa
Age
18 years and over
People
1,010 worldwide
Run by
AstraZeneca AB
See details and how to join2025-524688-19-00 · EU 2025-524688-19-00
Phase 3Taking people
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
Where
Bialystok, Bolesławiec, Chorzów, Katowice, Libiąż, Lodz, Lublin, Olsztyn, Piotrkow Trybunalski, Poznan, Puławy, Rzeszow, Torun, Warsaw, Wroclaw, Zamość, Żyrardów
Age
45 years and over
People
1,778 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07797335
No phaseTaking people
INNODIA Family & Friends Early-Stage T1D Detection Protocol
Where
Katowice
Age
1 year to 45 years
People
30,000 worldwide
Run by
INNODIA iVZW
See details and how to joinNCT07118098
Phase 2Taking people
Treatment of Presymptomatic (Stage 1) Type 1 Diabetes Pediatric Patients With Treg Cell Preparations and Anti-CD20 Antibody
Where
Bialystok, Gdansk, Katowice, Lodz, Lublin, Opole, Rzeszow, Szczecin, Warsaw, Wroclaw
Age
3 years to 18 years
People
150
Run by
PolTREG S.A.
See details and how to joinNCT06688331 · EU 2023-505226-33-00
No phaseEnrolling by invitation
Body Composition, Fitness, and Thermoregulation in Young Boys With Type I Diabetes vs. Healthy Soccer Players
Where
Poznan
Age
15 years to 17 years
People
40
Run by
Paweł Korman
See details and how to joinNCT06676878
No phaseNot yet taking people in Poland
Time in rANge vs. Time in nOrmal Glycemia for Better Glycemic Control
Where
Warsaw
Age
5 years to 18 years
People
120 worldwide
Run by
University Hospital, Motol
See details and how to joinNCT07376850
No phaseTaking people
"Sexual Activity and Hypoglycemia Risk in Adults With Type 1 or Type 2 Diabetes Using Insulin Therapy and Continuous Glucose Monitoring"
Where
Warsaw
Age
18 years and over
People
100
Run by
Medical University of Warsaw
See details and how to joinNCT07286500
No phaseTaking people
Insulin Therapy and Lipoproteins' Profile in Type 1 Diabetes.
Where
Poznan
Age
18 years to 35 years
People
300
Run by
Poznan University of Medical Sciences
See details and how to joinNCT02306005
Phase 2Taking people
Lisdexamphetamine Vs Methylphenidate for Pediatric Patients with ADHD and Type 1 Diabetes
Where
Gdansk, Katowice, Lodz, Opole, Warsaw
Age
8 years to 198 months
People
150
Run by
Medical University of Lodz
See details and how to joinNCT05957055 · EU 2023-506862-30-00